PHM from Pittsburgh

Vaccine Preventable Illnesses - Episode 7 - Pertussis
Target Audience:
This activity is directed to physicians, medical students, nurse practitioners, nurses, and physician assistants.
Objectives:
Upon completion of this activity, participants should be able to:
• Describe Pertussis pathogen and its infectivity.
• Apply appropriate treatment strategies for Pertussis in unvaccinated individuals and evaluate vaccine effectiveness.
• Assess the historical effectiveness of Pertussis vaccination in the United States.
Faculty: Course Directors:
Glenn Rapsinski MD, PhD - Assistant Professor of Pediatrics University of Pittsburgh School of Medicine
No relationships with industry relevant to the content of this educational activity have been disclosed.

Jonathan Albert MD -  Assistant Professor of Pediatrics University of Pittsburgh School of Medicine, Associate Director of the Pediatric Infectious Diseases Fellowship.
No relationships with industry relevant to the content of this educational activity have been disclosed.

Tony R. Tarchichi, MD — Associate Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) 

         No relationships with industry relevant to the content of this educational activity have been disclosed.


Conflict of Interest Disclosure:
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Accreditation Statement:
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh School of Medicine designates thisenduring material activity for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Disclaimer Statement:
The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Released 4/15/2026, Expires 4/15/2029
Below is a link to the course EM_188381 that is accredited for 0.75 credits. 
https://cme.hs.pitt.edu/ISER/app/learner/loadModule?moduleId=26424&dev=true

Vaccine Preventable Illnesses - Episode 6 - Tetanus & Hepatitis B
Target Audience:
This activity is directed to physicians, medical students, nurse practitioners, nurses, and physician assistants.
Objectives:
Upon completion of this activity, participants should be able to:
• Describe Tetanus & Hepatitis B pathogens and their infectivity.
• Apply appropriate treatment strategies for Tetanus and Hepatitis B in unvaccinated individuals and evaluate vaccine effectiveness.
• Assess the historical effectiveness of Tetanus and Hepatitis B vaccination in the United States.
Faculty: Course Directors:
Glenn Rapsinski MD, PhD - Assistant Professor of Pediatrics University of Pittsburgh School of Medicine
No relationships with industry relevant to the content of this educational activity have been disclosed.

Marian Michaels MD, MPH - Professor of Pediatrics and Surgery, University of Pittsburgh School of Medicine
Dr. Michaels disclosed she has received grant support from Merck inc, CDC and NIH.  

Tony R. Tarchichi, MD — Associate Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) 

         No relationships with industry relevant to the content of this educational activity have been disclosed.


Conflict of Interest Disclosure:
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Accreditation Statement:
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh School of Medicine designates thisenduring material activity for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Disclaimer Statement:
The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Released 4/15/2026, Expires 4/15/2029
Below is a link to the course EM_188381 that is accredited for 0.75 credits. 
https://cme.hs.pitt.edu/ISER/app/learner/loadModule?moduleId=26420&dev=true

Vaccine Preventable Illnesses - Episode 5 - Haemophilus Influenzae Type B & Pneumococcus
Target Audience:
This activity is directed to physicians, medical students, nurse practitioners, nurses, and physician assistants.
Objectives:
Upon completion of this activity, participants should be able to:
• Describe Haemophilus Influenzae Type B & Pneumococcus pathogens and their infectivity.
• Apply appropriate treatment strategies for Haemophilus Influenzae Type B & Pneumococcus in unvaccinated individuals and evaluate vaccine effectiveness.
• Assess the historical effectiveness of Haemophilus Influenzae Type B & Pneumococcus vaccination in the United States.
Faculty: Course Directors:
Michael Green MD, MPH - Professor of Pediatrics and Surgery and Clinical and Translational Science at the University of Pittsburgh School of Medicine.
Dr. Green has disclosed he is on the Data Monitoring Commiittees for ITB-MED and Bristol Myers Squibb inc. 

Philana Lin MD, MSc -Associate Professor of Pediatrics at University of Pittsburgh School of Medicine.; Division director Pediatric Infectious Disease
 No relationships with industry relevant to the content of this educational activity have been disclosed.


Tony R. Tarchichi, MD — Associate Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) 

         No relationships with industry relevant to the content of this educational activity have been disclosed.


Conflict of Interest Disclosure:
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Accreditation Statement:
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh School of Medicine designates thisenduring material activity for a maximum of 1 AMA PRA Category 1 CreditsTM.Physicians should only claim credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Disclaimer Statement:
The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Released 4/15/2026, Expires 4/15/2029
Below is a link to the course EM_188381 that is accredited for 1 credits. 
https://cme.hs.pitt.edu/ISER/app/learner/loadModule?moduleId=26423&dev=true

Vaccine Preventable Illnesses - Episode 4 - Polio, Mumps and Rubella 
Target Audience:
This activity is directed to physicians, medical students, nurse practitioners, nurses, and physician assistants.
Objectives:
Upon completion of this activity, participants should be able to:
• Describe Polio, Mumps and Rubella viruses and their infectivity.
• Apply appropriate treatment strategies for Polio, Mumps and Rubella virus in unvaccinated individuals and evaluate vaccine effectiveness.
• Assess the historical effectiveness of Polio, Mumps and Rubella vaccination in the United States.
Faculty: Course Directors:
Megan Culler Freeman MD, PhD - Assistant Professor of Pediatrics University of Pittsburgh School of Medicine
Dr. Freeman has disclosed she has received grant funding from Icosavax inc. 

Marian Michaels MD, MPH - Professor of Pediatrics and Surgery, University of Pittsburgh School of Medicine
Dr. Michaels disclosed she has received grant support from Merck inc, CDC and NIH.  

Tony R. Tarchichi, MD — Associate Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) 

         No relationships with industry relevant to the content of this educational activity have been disclosed.


Conflict of Interest Disclosure:
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Accreditation Statement:
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh School of Medicine designates thisenduring material activity for a maximum of 1 AMA PRA Category 1 CreditsTM.Physicians should only claim credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Disclaimer Statement:
The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Released 4/15/2026, Expires 4/15/2029
Below is a link to the course EM_188381 that is accredited for 1 credits. 
https://cme.hs.pitt.edu/ISER/app/learner/loadModule?moduleId=26422&dev=true

Episode: Vaccine Preventable Illnesses - Episode 3 - Varicella and Rotavirus
Target Audience:
This activity is directed to physicians, medical students, nurse practitioners, nurses, and physician assistants.
Objectives:
Upon completion of this activity, participants should be able to:
• Describe Rotavirus and Varicella viruses and their infectivity.
• Apply appropriate treatment strategies for Rotavirus and Varicella virus in unvaccinated individuals and evaluate vaccine effectiveness.
• Assess the historical effectiveness of Rotavirus and Varicella vaccination in the United States.
Faculty: Course Directors:
Jonathan Albert MD -  Assistant Professor of Pediatrics University of Pittsburgh School of Medicine, Associate Director of the Pediatric Infectious Diseases Fellowship.
No relationships with industry relevant to the content of this educational activity have been disclosed.

Brian Campfield MD - Assistant Professor of Pediatrics - University of Pittsburgh School of Medicine, Division of Infectious diseases
Dr. Campfield disclosed he is a consultant for Pfizer inc. 

Tony R. Tarchichi, MD — Associate Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) 

         No relationships with industry relevant to the content of this educational activity have been disclosed.


Conflict of Interest Disclosure:
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Accreditation Statement:
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh School of Medicine designates thisenduring material activity for a maximum of 0.75 AMA PRA Category 1 CreditsTM.Physicians should only claim credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Disclaimer Statement:
The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Released 4/15/2026, Expires 4/15/2029
Below is a link to the course EM_188381 that is accredited for 0.75 credits. 
https://cme.hs.pitt.edu/ISER/app/learner/loadModule?moduleId=26421&dev=true